The Zombie Pattern: How Distressed Companies Drain Before They Fall

A company almost never dies the way a headline suggests — suddenly, on a single bad day. It drains. Slowly. Capital that should rebuild the business is redirected: to buybacks, to dividends, to debt that gets rolled rather than repaid, and sometimes straight up the ownership chain to the people who control it. By the time "distress" appears in the financial statements, the extraction has usually been running for years.

This week offered the pattern in two very different forms.

The macro version. Aswath Damodaran's latest 2026 data update on dividends and buybacks lays out an uncomfortable arithmetic. In 2025, U.S. companies generated roughly $1.66 trillion in free cash flow to equity — yet returned about $4.1 trillion to shareholders ($2.55T in dividends, $1.53T in buybacks). In 2026, S&P 500 buybacks are again on pace to exceed a trillion dollars, outrunning dividends. Returning more than you produce is not automatically reckless; mature firms with few good projects should return cash. But the same window also has roughly $586 billion in debt coming due across the S&P 1500, with the most leveraged names struggling just to service interest. When cash flows out the front door for buybacks while obligations pile up at the back, reinvestment is the line item that silently gets cut first.

The micro version. In Korea, KOSDAQ-listed Selfyglobal (068940) shows what the same logic looks like inside a single small-cap. After a leveraged buyout group took control in 2022, the company saw fund outages and accounting irregularities, and roughly ₩11 billion in alleged embezzlement and breach of trust by former management. The Korea Exchange extended its trading suspension on June 8, 2026, leaving the suspension in place until the courts rule on the delisting dispute. The throughline is the same as the macro story: resources flowing toward whoever sits at the top of the structure, not back into the business that minority shareholders actually own.

The Korea parallel. This isn't a handful of outliers. RaymondsRisk built its index across 3,109 companies precisely because the reinvestment signal is systemic, not anecdotal. The Reinvestment Intensity Index (RII) measures reinvestment rate, capex volatility, and the gap between the capex a firm's growth implies and the capex it actually books. In testing, the signal separated stressed from healthy names with an effect size of d>0.8 — large by any social-science standard — and it moved before the balance sheet did.

The academic frame. The "zombie firm" is not a metaphor invented for marketing. Caballero, Hoshi, and Kashyap (2008), in their study of Japan's lost decade, defined zombies as firms kept alive by cheap credit while starving healthy competitors of capital and depressing aggregate restructuring. Banerjee and Hofmann, writing for the BIS (2018), documented that the share of zombie firms across advanced economies has ratcheted higher with each cycle, tied closely to easy financing and weak exit pressure. Both literatures converge on one point relevant to investors: a zombie's defining trait is not a single bad year — it is the persistent failure to reinvest, masked by continued access to cash.

What it means for the individual investor. The retail shareholder almost never sees the moment of collapse coming, because the collapse isn't a moment. It's a trend — deferred capex, rising payouts or related-party flows, debt rolled instead of retired — that is fully legible in the data long before it is legible in the price. Leading indicators like RII exist to compress that gap. The practical takeaway is modest but durable: when a company returns more than it earns and reinvests less than its growth requires, treat it as a question to answer, not a generosity to applaud.

#RaymondsRisk #RelationalRisk #CorporateGovernance #ZombieFirms #Reinvestment #Buybacks